Gw pharmaceuticals plc (GWPH)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17
Cash flows from operating activities
Net loss

33,080

-9,019

-55,979

-122,101

-285,860

-305,257

-295,167

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Foreign exchange loss

-1,972

-2,709

-324

-2,791

-5,763

-5,839

-4,917

0

0

0

Share-based compensation

48,249

48,030

45,316

42,622

40,001

35,718

31,627

0

0

0

Depreciation and amortization

9,479

9,240

9,630

9,749

9,771

9,661

9,290

0

0

0

Deferred income taxes

-

-

-

-

-

-430

-317

0

0

0

Other

0

-

-

-

-

-

-

-

-

0

Changes in operating assets and liabilities:
Accounts receivable, net

43,255

44,623

39,816

30,207

17,384

2,706

804

0

0

0

Inventory

45,758

51,125

52,021

58,055

43,451

28,484

13,646

0

0

0

Prepaid expenses and other current assets

3,580

9,831

18,504

17,588

-10,988

-11,370

-14,489

0

0

0

Other assets

-4,114

-3,888

-2,921

-1,346

-217

445

564

0

0

0

Accounts payable

7,392

805

-2,372

3,161

4,175

2,829

2,238

0

0

0

Current tax liabilities

1,417

-963

277

111

-1,936

-3,966

54

0

0

0

Accrued liabilities

19,829

43,110

35,118

29,733

32,778

19,445

16,507

0

0

0

Other liabilities

-2,875

-1,914

-1,533

0

0

0

-

-

-

-

Other current liabilities

-

-

-

-

-

-

-

-

0

-

Long-term liabilities

-

-

-

-

-

-

-

-

0

-

Net cash used in operating activities

-83,685

-123,469

-181,982

-246,320

-247,751

-254,770

-231,868

0

0

0

Cash flows from investing activities
Additions to property, plant and equipment

34,660

40,386

48,602

50,141

48,332

42,301

31,362

0

0

0

Additions to capitalized software

0

-

-

-

0

-

-

-

-

-

Additions to intangible assets

0

-

-

-

-

1,112

2,042

0

0

0

Net cash used in investing activities

60,615

61,629

54,269

53,347

-48,788

-42,896

-32,887

0

0

0

Cash flows from financing activities
Proceeds from issuance of ordinary shares, net of issuance costs

-

-

-

-

-

0

-

-

-

0

Proceeds from exercise of stock options

2,108

2,878

0

0

0

-

620

0

0

0

Payments on finance leases

283

389

357

358

358

251

0

0

0

-

Payments on landlord financing obligation

548

543

534

529

528

527

522

0

0

0

Net cash (used in) provided by financing activities

1,277

1,946

326,625

327,246

325,143

324,479

297,754

0

0

0

Effect of exchange rate changes on cash

1,059

5,330

857

9,470

5,830

5,457

-240

0

0

0

Net decrease in cash and cash equivalents

-20,734

-54,564

199,769

143,743

34,434

32,270

32,759

0

0

0

Supplemental disclosure of cash flow information:
Income taxes paid

10,384

10,462

0

0

0

-

0

0

0

-

Interest paid

1,107

1,087

1,003

1,028

1,073

1,133

0

0

0

-

Supplemental disclosure of noncash information:
Property and equipment purchases in accounts payable and accrued liabilities

1,870

923

3,433

2,896

1,112

2,221

0

0

0

-

Right-of-use asset obtained in exchange for operating liabilities

0

-

-

-

-

-

-

-

-

-